Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Market for Pain Management Drugs and Devices
Chapter 3 Market Overview
- History of Pain and Pain Treatment
- The Perception of Pain
- Types of Pain
- Acute Pain
- Chronic Pain
- Assessment of Pain
- Subjective
- Objective
- How Pain is Diagnosed
- How Pain is Treated
- Physical Pain Treatment Modalities
- Acupuncture/Acupressure
- Ice (Cryotherapy)
- Joint Mobilization
- Manipulation
- Massage
- Traction
- Radiation Therapy
- Radio-Frequency Neuroablation and Epiduroscopy
- Surgery
- Whirlpool Bath (Thermotherapy)
- Psychological Pain Therapies
- Biofeedback
- Hypnosis
- Behavior Modification/Operant Conditioning
- Relaxation and Stress Management Training
- Imagery
- Autogenic Training
- Psychosocial Interventions
- Distraction and Reframing
Chapter 4 Market Dynamics
- Overview
- Market Drivers
- Market Restraints
- Market Challenges
Chapter 5 Market Breakdown by Product
- Market Overview
- Market Share and Forecast
- Pharmaceuticals
- Narcotic Drugs
- Non-narcotic Drugs
- Antimigraine Drugs
- Anesthesia Drugs
- Other Drugs
- Pain Management Devices
- Neurostimulation Devices
- Infusion Pumps
- Ablation Devices
Chapter 6 Market Breakdown by Application
- Market Overview
- Market Share and Forecast
- Musculoskeletal Pain
- Post-operative Pain
- Neuropathic Pain
- Cancer Pain
- Migraine/Headache
- Other Applications
- HIV/AIDS
- Burn Pain
- Dental Pain
Chapter 7 Market Breakdown by Region
- Market Overview
- Market Share Forecast
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Italy
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Chapter 8 ESG Development
- Introduction to ESG
- Sustainability in the Pain Management Drugs and Devices Industry: An ESG Perspective
- Key ESG Issues
- ESG Ranking
- Consumer Attitudes toward ESG in the Market for Pain Management Drugs and Devices
- Case Study
- Concluding Remarks
Chapter 9 Emerging Technologies
- Overview
- Technology Advancements in Opioid Drugs
- Technology Advancements in Non-narcotic Drugs
- Technology Advancements in Neuromodulation Devices
- Technology Advancements in Infusion Pumps
- Trends in Pain Management
- Pharmacogenomics
- AI Pain Management
Chapter 10 Clinical Trials and Patent Analysis
- Overview of Clinical Trials
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Clinical Trials Analysis by Region
- Overview of Patent Analysis
- Patents by Year
- Patents by Top-Ranking Applicant
- Patents by Top-Ranking Patent Holder
- Patents by Jurisdiction
Chapter 11 Competitive Intelligence
- Market Analysis
- Market for Pain Management Drugs
- Market for Pain Management Medical Devices
- Funding
- Recent Developments by Key Market Players
Chapter 12 Company Profiles
- ABBOTT LABORATORIES
- ABBVIE INC
- ASSERTIO HOLDINGS INC.
- ASTRAZENECA PLC
- BOSTON SCIENTIFIC CORP.
- ELI LILLY & CO.
- ENDO INTERNATIONAL PLC
- ENOVIS CORP.
- GLAXOSMITHKLINE
- GRUNENTHAL GMBH
- JOHNSON & JOHNSON
- MEDTRONIC PLC
- NOVARTIS INTERNATIONAL AG
- VERTEX PHARMACEUTICALS INC.
- VIATRIS INC.
List of Tables
Summary Table B: Global Market for Pain Management Drugs and Devices, by Region, Through 2028
Summary Table A: Global Market for Pain Management Drugs and Devices, by Product, Through 2028
Table 1: Objective Signs of Pain
Table 2: Prevalence of Chronic Pain in Older Adults by Site
Table 3: Opioid Lawsuit Settlements
Table 4: Global Market for Pain Management Drugs and Devices , by Product, Through 2028
Table 5: FDA Pain Management Drug Approvals, 2020-2023
Table 6: Pain Management Major Drugs by Company
Table 7: Emerging Pain Therapeutics
Table 8: Global Market for Pain Management Pharmaceuticals, by Region, Through 2028
Table 9: Global Market for Pain Management Pharmaceuticals, by Product, Through 2028
Table 10: Classification of Narcotic Analgesics Based on Chemical Structure
Table 11: Most Common Narcotic Analgesics
Table 12: Approved Labeling Describing Abuse-Deterrent Properties
Table 13: Global Market for Narcotic Drugs, by Region, Through 2028
Table 14: Global Market for Non-narcotic Drugs, by Region, Through 2028
Table 15: Global Market for Antimigraine Drugs, by Region, Through 2028
Table 16: Most Commonly Used General Anesthetic Agents
Table 17: Most Commonly Used Topical and Local Anesthetic Agents
Table 18: Global Market for Anesthesia Drugs, by Region, Through 2028
Table 19: Global Market for Other Drugs, by Region, Through 2028
Table 20: Global Market for Pain Management Devices, by Region, Through 2028
Table 21: Global Market for Pain Management Devices, by Type, Through 2028
Table 22: Spinal Cord Stimulation Systems By Major Companies
Table 23: TENS Devices by Major Companies
Table 24: Global Market for Neurostimulation Devices, by Region, Through 2028
Table 25: PCA Devices by Companies
Table 26: Global Market for Infusion Pumps, by Region, Through 2028
Table 27: Global Market for Ablation Devices, by Region, Through 2028
Table 28: Global Market for Pain Management Drugs and Devices, by Application, Through 2028
Table 29: Pharmacological Musculoskeletal Pain Management
Table 30: Global Market for Musculoskeletal Pain, by Region, Through 2028
Table 31: Pharmacological Post-operative Pain Management
Table 32: Cumulative Volumes of Hip and Knee Procedures, 2012-2021
Table 33: Global Market for Post-operative Pain, by Region, Through 2028
Table 34: Neuropathic Pain Medication
Table 35: Global Market for Neuropathic Pain, by Region, Through 2028
Table 36: Cancer Pain Medication
Table 37: Global Market for Cancer Pain, by Region, Through 2028
Table 38: Global Market for Migraine/Headache Pain, by Region, Through 2028
Table 39: Global Market for Other Pain Applications, by Region, Through 2028
Table 40: Global Market for Pain Management Drugs and Devices, by Region, Through 2028
Table 41: ESG Ranking of Major Pharma Players for Pain Therapeutics,2022
Table 42: ESG Rankings for Major Pain Management Drug and Device Companies, 2023*
Table 43: ESG: Environmental Overview
Table 44: ESG: Social Overview
Table 45: ESG: Governance Overview
Table 46: Clinical Trials on Pain Management, by Type of Study, September 2023
Table 47: Clinical Trials on Pain Mangement, by Status, September 2023
Table 48: Clinical Trials on Pain Mangement, by Phase, September 2023
Table 49: Clinical Trials on Pain Mangement, by Region, September 2023
Table 50: Number of Patents by Top-Ranking Applicant, 2018-2022
Table 51: Number of Patents by Top-Ranking Patent Holder, 2018-2022
Table 52: Number of Patents, by Jurisdiction, 2018-2022
Table 53: Global Market Ranking in the Neuromodulation Segment, by Manufacturer, 2022
Table 54: Global Market Ranking in the Infusion Pumps Segment, by Manufacturer, 2022
Table 55: Recent Development, 2020-2023
Table 56: Abbott Laboratories: Financials, 2021 and 2022
Table 57: Abbott Laboratories: Product Portfolio
Table 58: Abbott Laboratories.: Key Developments, 2021-2022
Table 59: AbbVie Inc.: Financials, 2021 and 2022
Table 60: AbbVie Inc.: Key Developments, 2021 and 2022
Table 61: Assertio Holdings Inc.: Financials, 2021 and 2022
Table 62: Boston Scientific Corp.: Financials, 2021 and 2022
Table 63: Boston Scientific Corp.: Product Portfolio
Table 64: Eli Lily & Co.: Financials, 2021 and 2022
Table 65: Eli Lily & Co.: Key Developments, 2021-2023
Table 66: Endo International plc: Financials, 2021 and 2022
Table 67: Endo International plc: Key Developments, 2021-2023
Table 68: Enovis Corp.: Financials, 2021 and 2022
Table 69: GlaxoSmithKline: Financials, 2021 and 2022
Table 70: Grünenthal GmbH: Financials, 2021 and 2022
Table 71: Grünenthal GmbH: Key Developments, 2022
Table 72: Johnson & Johnson: Financials, 2021 and 2022
Table 73: Medtronic plc: Financials, 2021 and 2022
Table 74: Medtronic plc: Product Portfolio
Table 75: Medtronic plc: Key Developments, 2020-2023
Table 76: Novartis International AG: Financials, 2021 and 2022
Table 77: Vertex Pharmaceuticals Inc.: Key Developments, 2023
Table 78: Viatris Inc.: Financials, 2021 and 2022
Table 79: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Pain Management Drugs and Devices, by Product, 2020-2028
Summary Figure B: Global Market for Pain Management Drugs and Devices, by Region, 2020-2028
Figure 1: Pain Management Techniques
Figure 2: Pain Management Drugs and Devices: Market Dynamics
Figure 3: Common Chronic Pain: Reasons
Figure 4: Cancer Incidence, by Region, 2020 vs. 2040
Figure 5: Percentage of Global Population above 65 Years, 2018-2022
Figure 6: Global Market Shares of Pain Management Drugs and Devices , by Product, 2022
Figure 7: Global Market Shares of Pain Management Pharmaceuticals, by Product, 2022
Figure 8: Proportion of the Individual Opioid Consumption in Morphine Milligram Equivalents (MME) by Country Income in 2009 vs. 2019
Figure 9: Total Number of Opioid Prescriptions Dispensed in the U.S., 2010-2020
Figure 10: Opioid Dispensing Rate per 100 Persons, U.S, 2010-2020
Figure 11: Global Market for Narcotic Drugs, by Region, 2020-2028
Figure 12: Number of Drug Overdose Deaths in the U.S., 2019-2021
Figure 13: Global Market for Non-narcotic Drugs, by Region, 2020-2028
Figure 14: Symptomatic Medication by Headache Severity
Figure 15: Preventive Drugs for Migraines
Figure 16: Global Market for Antimigraine Drugs, by Region, 2020-2028
Figure 17: Global Market for Anesthesia Drugs, by Region, 2020-2028
Figure 18: Global Market for Other Drugs, by Region, 2020-2028
Figure 19: Global Market Shares of Pain Management Devices, by Type, 2022
Figure 20: SCS Application for Pain Management
Figure 21: Global Market for Neurostimulation Devices, by Region, 2020-2028
Figure 22: Global Market for Infusion Pumps, by Region, 2020-2028
Figure 23: Global Market for Ablation Devices, by Region, 2020-2028
Figure 24: Global Market Shares of Pain Management Drugs and Devices, by Application, 2022
Figure 25: Global Market for Musculoskeletal Pain, by Region, 2020-2028
Figure 26: Global Market for Post-operative Pain, by Region, 2020-2028
Figure 27: Classification of Neuropathic Pain
Figure 28: Global Market for Neuropathic Pain, by Region, 2020-2028
Figure 29: Causes of Cancer Pain
Figure 30: Global Market for Cancer Pain, by Region, 2020-2028
Figure 31: Global Market for Migraine/Headache Pain, by Region, 2020-2028
Figure 32: Burn Pain Management Approach
Figure 33: Burn Pain Management Approach
Figure 34: Global Market Shares of Pain Management Drugs and Devices, by Region, 2022
Figure 35: North American Market for Pain Management, 2020-2028
Figure 36: European Market for Pain Management, 2020-2028
Figure 37: Asia-Pacific Market for Pain Management, 2020-2028
Figure 38: Rest of the World Market for Pain Management, 2020-2028
Figure 39: ESG Pillars
Figure 40: Advantages of ESG for Companies
Figure 41: ESG-Adoption Level across Industries
Figure 42: Hospitals: Sustainability Priorities
Figure 43: Novartis: ESG Rating
Figure 44: Novartis: Major ESG Activities, 2022
Figure 45: Number of Patents Granted, by Year, 2018-2022
Figure 46: Abbott Laboratories: Financials, 2021 and 2022
Figure 47: Abbott Laboratories: Revenue Shares, by Business Unit, 2022
Figure 48: Abbott Laboratories: Revenue Shares, by Region, 2022
Figure 49: AbbVie Inc.: Financials, 2021 and 2022
Figure 50: AbbVie Inc.: Revenue Shares, by Business Unit, 2022
Figure 51: AbbVie Inc.: Revenue Shares, by Region, 2022
Figure 52: Assertio Holdings Inc.: Financials, 2021 and 2022
Figure 53: Assertio Holdings Inc.: Revenue Shares, by Business Unit, 2022
Figure 54: Boston Scientific Corp.: Financial, 2021 and 2022
Figure 55: Boston Scientific Corp.: Revenue Shares, by Business Unit, 2022
Figure 56: Boston Scientific Corp.: Revenue Shares, by Country/Region, 2022
Figure 57: Eli Lily & Co.: Annual Revenue, 2021 and 2022
Figure 58: Eli Lily & Co.: Revenue Shares, by Business Unit, 2022
Figure 59: Eli Lily & Co.: Revenue Shares, by Region, 2022
Figure 60: Endo International plc: Financials, 2021 and 2022
Figure 61: Endo International plc: Revenue Shares, by Business Unit, 2022
Figure 62: Enovis Corp.: Financials, 2021 and 2022
Figure 63: Enovis Corp.: Revenue Shares, by Business Unit, 2022
Figure 64: Enovis Corp.: Revenue Shares, by Country/Region, 2022
Figure 65: GlaxoSmithKline: Financial, 2021 and 2022
Figure 66: GlaxoSmithKline: Revenue Shares, by Business Unit, 2022
Figure 67: GlaxoSmithKline: Revenue Shares, by Region, 2022
Figure 68: Grünenthal GmbH: Financials, 2021 and 2022
Figure 69: Grünenthal GmbH: Market Share, by Business Segment, 2022
Figure 70: Grünenthal GmbH: Market Share, by Region, 2022
Figure 71: Johnson & Johnson: Financials, 2021 and 2022
Figure 72: Johnson & Johnson: Revenue Shares, by Business Segment, 2022
Figure 73: Johnson & Johnson: Revenue Shares, by Country/Region, 2022
Figure 74: Medtronic plc: Financials, 2021 and 2022
Figure 75: Medtronic plc: Market Share, by Business Unit, 2022
Figure 76: Medtronic plc: Market Share, by Region, 2022
Figure 77: Novartis International AG: Financials, 2021 and 2022
Figure 78: Novartis International AG: Revenue Shares, by Business Unit, 2022
Figure 79: Novartis AG: Revenue Shares, by Region, 2022
Figure 80: Viatris Inc.: Financials, 2021 and 2022
Figure 81: Viatris Inc.: Revenue Shares, by Region, 2022
